CBT
Get informed when a big investor buys or sells
+ FollowUndervalued by 202.9% based on the discounted cash flow analysis.
| Market cap | $4.40 Billion |
|---|---|
| Enterprise Value | $5.44 Billion |
| Dividend Yield | $1.82 (2.14%) |
| Earnings per Share | $6.07 |
| Beta | 0.84 |
| Outstanding Shares | 51,600,000 |
| P/E Ratio | 23.6 |
|---|---|
| PEG | -25.09 |
| Price to Sales | 1.19 |
| Price to Book Ratio | 2.53 |
| Enterprise Value to Revenue | 1.5 |
| Enterprise Value to EBIT | 10.73 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.81 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0698▼ 57.80% |
|---|---|
| Total Calls | 220,700▲ 421.75% |
| Total Puts | 15,400▼ 43.80% |
Holdings and activity of institutional investors.
| Ownership % | 115.27%▲ 18.09% |
|---|---|
| Total Invested | $4.99B▲ 29.53% |
| Investors Holding | 394▲ 17.00% |
No data